September 2022 in “Journal of The American Academy of Dermatology” This review summarizes existing literature on COVID-19-associated alopecia, finding that androgenic alopecia may increase COVID-19 risk, while telogen effluvium often follows infection.
7 citations
,
February 2022 in “JAAD International” This review suggests that alopecia areata may occur as a dermatologic manifestation of COVID-19, often appearing 1 to 2 months after infection; further research is needed to clarify this association.
44 citations
,
January 2021 in “Dermatologic Therapy” This study suggests that COVID-19 infection may trigger telogen effluvium, a condition of hair shedding, though medication side effects and pandemic-related stress cannot be excluded as contributing factors.
40 citations
,
May 2020 in “Cureus” This review discusses the causes, diagnosis, and treatment of telogen effluvium and reports no new clinical findings; the authors underscore the importance of identifying and eliminating causative factors.
31 citations
,
May 2020 in “Dermatologic Therapy” Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.
August 2019 in “DOAJ (DOAJ: Directory of Open Access Journals)” This essay reviews issues related to telogen effluvium, including diagnosis, classification, and management, but it reports no new clinical findings.
148 citations
,
December 2018 in “Journal of autoimmunity” This review discusses genetic and environmental factors contributing to autoimmunity in alopecia areata and reports no new clinical findings, emphasizing the need for further study on its aetiology and pathophysiology.
34 citations
,
October 2017 in “Archivos Argentinos De Pediatria” This review discusses the clinical characteristics, diagnosis, and treatment of alopecia areata, exploring potential environmental, immunological, and genetic factors involved in its development, but reports no new research findings.
234 citations
,
December 1996 in “Journal of The American Academy of Dermatology” The authors concluded that chronic telogen effluvium in middle-aged women presents distinct clinical and histological features that differ from androgenetic alopecia and acute telogen effluvium.
75 citations
,
October 1996 in “Dermatologic Clinics” This review examines chronic telogen effluvium, highlighting its distinctive features and the need for reassurance about its non-progressive nature, but reports no new clinical results.
69 citations
,
March 1993 in “Archives of Dermatology” This article proposes five mechanisms for telogen effluvium based on changes in the follicular cycle, which are supported by clinical findings, highlighting the condition's diverse causes.
